Royal Bank Of Canada Oric Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 6,924 shares of ORIC stock, worth $58,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,924

Previous 6,291 10.06%

Holding current value

$58,854

Previous $44,000 59.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.52 - $11.9 $4,760 - $7,532	633 Added 10.06%	6,924 $70,000
Q2 2024 Aug 14, 2024	BUY	$6.63 - $12.93 $32,540 - $63,460	4,908 Added 354.88%	6,291 $44,000
Q1 2024 Nov 05, 2024	SELL	$8.04 - $16.03 $39,460 - $78,675	-4,908 Reduced 78.02%	1,383 $19,000
Q1 2024 May 15, 2024	SELL	$8.04 - $16.03 $81,549 - $162,592	-10,143 Reduced 88.0%	1,383 $19,000
Q4 2023 Feb 14, 2024	BUY	$5.41 - $9.43 $26,898 - $46,885	4,972 Added 75.86%	11,526 $106,000
Q3 2023 Nov 14, 2023	BUY	$6.05 - $9.28 $15,022 - $23,042	2,483 Added 60.99%	6,554 $39,000
Q2 2023 Aug 14, 2023	BUY	$4.95 - $8.4 $20,121 - $34,146	4,065 Added 67750.0%	4,071 $31,000
Q1 2023 May 15, 2023	SELL	$4.26 - $6.75 $788 - $1,248	-185 Reduced 96.86%	6 $0
Q4 2022 Feb 14, 2023	SELL	$2.41 - $5.89 $2,159 - $5,277	-896 Reduced 82.43%	191 $1,000
Q3 2022 Nov 14, 2022	BUY	$3.15 - $5.24 $1,795 - $2,986	570 Added 110.25%	1,087 $3,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.07 $9,247 - $24,214	-3,425 Reduced 86.88%	517 $2,000
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $9,792 - $34,727	-2,157 Reduced 35.37%	3,942 $21,000
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $32,775 - $55,398	2,729 Added 80.98%	6,099 $90,000
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $21,465 - $34,047	1,350 Added 66.83%	3,370 $70,000
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $35,087 - $51,186	2,020 New	2,020 $36,000

Others Institutions Holding ORIC

# of Institutions

124

Shares Held

66.6M

Call Options Held

7.8K

Put Options Held

700

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Oric Pharmaceuticals, Inc. Transaction History